|

THRV-1268 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2/3: 1

Top Sponsors

  • Thryv Therapeutics, Inc.1

Indications

  • Long QT Syndrome (LQTS) 21
  • Heart Disease1

Scottsdale, Arizona1 trial

Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)

Honor Health Research and Innovation Institute

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.